EMV Capital (AIM:EMVC) is buying key assets of biotech Destiny Pharma, which went into liquidation last month. The deal is worth up to £2.475 million and includes antibiotic technology XF-73, with phase III trials planned and a fundraising to support the new venture.
Ilika PLC (AIM:IKA, OTCQX:ILIKF) has launched its PRIMED programme to scale solid-state batteries for electric cars. The project involves Jaguar Land Rover and Oxford University and will build 50 ampere-hour prototypes at UKBIC in Coventry.
Rainbow Rare Earths Ltd (LSE:RBW, OTC:RBWRF) has improved test work at Phalaborwa, cutting cerium by 65% to boost product quality. The change reduces costs and simplifies processing, with chief executive George Bennett calling it a major achievement.
Oriole Resources PLC (AIM:ORR) reported strong results from maiden drilling at Mbe in Cameroon, confirming a mineralised zone over 500 metres. A resource estimate is due in the fourth quarter, supported by the encouraging gold intersections.
Helium One Global Ltd (AIM:HE1, OTCQB:HLOGF) is moving forward at Rukwa in Tanzania with new pump equipment from CenerTech Group. ESP operations are due in the fourth quarter, aimed at boosting flow rates and collecting more gas data.
Mosman Oil and Gas Ltd (AIM:MSMN) received approval from the Ute Mountain Ute Tribal Council for projects in Colorado. This clears the way for the Sagebrush well test once the Bureau of Indian Affairs process is complete.
Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.